2-氨基-4-(2-硝基苯基)丁酸乙酯 | 86499-33-4

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 中文名称: 2-氨基-4-(2-硝基苯基)丁酸乙酯
• 英文名称: ethyl 2-amino-4-(2-nitrophenyl)butyrate
• 英文别名: Ethyl 2-amino-4-(o-nitrophenyl)butyrate；ethyl 2-amino-4-(2-nitrophenyl)butanoate
• CAS: 86499-33-4
• 化学式: C₁₂H₁₆N₂O₄
• mdl: MFCD19556652
• 分子量: 252.27
• InChiKey: GWBJXBUPIPXINZ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  18
• 可旋转键数：
  6
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.416
• 拓扑面积：
  98.1
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  2-氨基-4-(2-硝基苯基)丁酸乙酯 在 palladium on activated charcoal 锂硼氢 、 氢气 作用下， 以 四氢呋喃 、 乙醇 、 二氯甲烷 为溶剂， 25.0 ℃ 、101.33 kPa 条件下， 反应 88.0h， 生成 2-<(tert-butoxycarbonyl)amino>-4-(2-aminophenyl)butan-1-ol
  参考文献：
  名称：

  Synthesis, Conformation, and Biological Activity of Teleocidin Mimics, Benzolactams. A Clarification of the Conformational Flexibility Problem in Structure−Activity Studies of Teleocidins

  摘要：

  Tumor-promoter teleocidins and their active congeners (indolactams) are known to exist in an equilibrium between at least two conformational states in solution, the twist and sofa form, due to cis-trans isomerization of the amide bond and the steric effects of substituents on the nine-membered lactam ring. Benzolactam-Vs, in which the indole ring of indolactams is replaced with a benzene ring, were designed and synthesized in an attempt to reproduce the active conformation of teleocidins. Among these benzolactams, eight-membered lactams (benzolactam-V8) can only exist in the twist form, and 9- and 10-membered lactams (benzolactam-V9 and -V10) exist exclusively in the sofa form in solution. The stronger biological activity of benzolactam-V-8-310 than that of indolactam-V (IL-V) and the inactivity of benzolactam-V-9-310 for differentiation inducing activity of HL-60 clearly indicated that the twist form is close to the active conformation of teleocidins.

  DOI：

  10.1021/ja953578v
• 作为产物：
  描述：

  2-硝基苯乙基溴 在 盐酸 、 氯化亚砜 、 sodium hydride 、 溶剂黄146 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 35.0h， 生成 2-氨基-4-(2-硝基苯基)丁酸乙酯
  参考文献：
  名称：

  Synthesis, Conformation, and Biological Activity of Teleocidin Mimics, Benzolactams. A Clarification of the Conformational Flexibility Problem in Structure−Activity Studies of Teleocidins

  摘要：

  Tumor-promoter teleocidins and their active congeners (indolactams) are known to exist in an equilibrium between at least two conformational states in solution, the twist and sofa form, due to cis-trans isomerization of the amide bond and the steric effects of substituents on the nine-membered lactam ring. Benzolactam-Vs, in which the indole ring of indolactams is replaced with a benzene ring, were designed and synthesized in an attempt to reproduce the active conformation of teleocidins. Among these benzolactams, eight-membered lactams (benzolactam-V8) can only exist in the twist form, and 9- and 10-membered lactams (benzolactam-V9 and -V10) exist exclusively in the sofa form in solution. The stronger biological activity of benzolactam-V-8-310 than that of indolactam-V (IL-V) and the inactivity of benzolactam-V-9-310 for differentiation inducing activity of HL-60 clearly indicated that the twist form is close to the active conformation of teleocidins.

  DOI：

  10.1021/ja953578v

文献信息

• 3-Amino-[1]-benzazepin-2-one-1-alkanoic acids
  申请人：Ciba-Geigy Corporation

  公开号：US04575503A1

  公开（公告）日：1986-03-11

  Variously substituted 1-carboxymethyl-3-(carboxymethylamino)-2,3,4,5-tetrahydro-1H-[1]benzazepin -2-ones and functional derivatives are angiotensin converting enzyme inhibitors and are useful as antihypertensive agents. Synthesis of, compositions and methods of treatment utilizing such compounds are included.

  取代基不同的1-羧甲基-3-(羧甲基氨基)-2,3,4,5-四氢-1H-[1]苯并氮杂䓬-2-酮及其功能性衍生物是血管紧张素转化酶抑制剂，并可作为抗高血压药使用。包括这些化合物的合成、组合物及治疗方法。
• 3-Amino-(1)-benzazepin-2-one-1-alkanoic acids
  申请人：Ciba-Geigy Corporation

  公开号：US04473575A1

  公开（公告）日：1984-09-25

  Variously substituted 1-carboxymethyl-3-(carboxymethylamino)-2,3,4,5-tetrahydro-1H-[1]benzazepin -2-ones and functional derivatives are angiotensin converting enzyme inhibitors and are useful as antihypertensive agents. Synthesis of, compositions and methods of treatment utilizing such compounds are included.

  各种取代的1-羧甲基-3-(羧甲基氨基)-2,3,4,5-四氢-1H-[1]苯并氮杂卓-2-酮及其功能衍生物是血管紧张素转化酶抑制剂，可用作抗高血压药。包括这些化合物的合成、组合物及治疗方法。
• US4410520A
  申请人：——

  公开号：US4410520A

  公开（公告）日：1983-10-18
• US4473575A
  申请人：——

  公开号：US4473575A

  公开（公告）日：1984-09-25
• US4575503A
  申请人：——

  公开号：US4575503A

  公开（公告）日：1986-03-11